ERBB2 and neoplasm: This is arguably a result of their tumor characteristics based on immunohistochemistry properties [estrogen receptor (ER), progesterone receptor (PR), human epidermal growth receptor-2 (HER-2), and Ki-67 proliferation index] (9–11).